TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery
Authors:
- Didier TchetcheDTDidier Tchetche
- Azeem LatibAzeem Latib
- Carmelo SgroiCSCarmelo Sgroi
- Ganesh ManoharanGMGanesh Manoharan
- Helge MöllmannHMHelge Möllmann
- Nicolas M. Van MieghemNMNicolas M. Van Mieghem
- 1 September 2016
- journal article
- Published by Europa Digital & Publishing in EuroIntervention
- Vol. 12 (Y) , Y22-Y27
Abstract
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Keywords
This publication has 13 references indexed in Scilit:
- Transcatheter aortic valve implantation (TAVI) in Germany 2008-2014: on its way to standard therapy for aortic valve stenosis in the elderly?EuroIntervention, 2016
- New-generation TAVI devices: description and specificationsEuroIntervention, 2014
- Caval-Aortic Access to Allow Transcatheter Aortic Valve Replacement in Otherwise Ineligible PatientsJACC, 2014
- First-in-human experience with the Medtronic CoreValve Evolut REuroIntervention, 2014
- Symetis ACURATE TF™ aortic bioprosthesisEuroIntervention, 2013
- St Jude Medical Portico valveEuroIntervention, 2012
- Edwards SAPIEN 3 valveEuroIntervention, 2012
- Direct Flow Medical valveEuroIntervention, 2012
- Registry of Transcatheter Aortic-Valve Implantation in High-Risk PatientsNew England Journal of Medicine, 2012
- Multidetector Computed Tomography in Transcatheter Aortic Valve ImplantationJACC: Cardiovascular Imaging, 2011